The acute-phase reactant C-reactive protein binds to phosphorylcholine- expressing Neisseria meningitidis and increases uptake by human phagocytes

Infection and Immunity

Volumn 76, Issue 3, 2008, Pages 1298-1304

  Casey, Rosalyn ^a   Newcombe, Jane ^a   McFadden, JohnJoe ^a   Bodman Smith, Katherine B ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; OPSONIN; PHOSPHORYLCHOLINE; CALCIUM;

ARTICLE; BACTERIUM PILUS; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; NEISSERIA MENINGITIDIS; NEUTROPHIL; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN TRANSPORT; CELL CULTURE; CELL LINE; DOSE RESPONSE; IMMUNOLOGY; METABOLISM; PHAGOCYTE;

C-REACTIVE PROTEIN; CALCIUM; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; MACROPHAGES; NEISSERIA MENINGITIDIS; NEUTROPHILS; PHAGOCYTES; PHOSPHORYLCHOLINE; PROTEIN BINDING;

EID: 40749136997     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00741-07     Document Type: Article

References (41)

1. Avrameas, S. 1969. Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies. Immunochemistry 6:43-52.
2. Bodman-Smith, K. B., R. E. Gregory, P. T. Harrison, and J. G. Raynes. 2003. C-reactive protein binds human FcγRIIa and FcγRIIB and is able to influence phagocytosis of erythrocytes by FcãR1 transfected cells. Immunology 110:28.
3. Bodman-Smith, K. B., R. E. Gregory, P. T. Harrison, and J. G. Raynes. 2004. FcγRIIa expression with FcγRI results in C-reactive protein- and IgG-mediated phagocytosis. J. Leukoc. Biol. 75:1029-1035.
4. Bodman-Smith, K. B., M. Mbuchi, F. J. Culley, P. A. Bates, and J. G. Raynes. 2002. C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses. Parasite Immunol. 24:447-454.
5. Bodman-Smith, K. B., A. J. Melendez, I. Campbell, P. T. Harrison, J. M. Allen, and J. G. Raynes. 2002. C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI). Immunology 107:252-260.
6. Borschsenius, F., J. N. Bruun, T. E. Michaelsen, and T. Tonjun. 1986. Serum C-reactive protein in systemic infections due to Neisseria meningitidis. NIPH Ann. 9:15-21.
7. Bredius, R. G., B. H. Derkx, C. A. Fijen, T. P. de Wit, M. De Haas, R. S. Weening, J. G. van de Winkel, and T. A. Out. 1994. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J. Infect. Dis. 170:848-853.
8. Briles, D. E., M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J. Exp. Med. 153:694-705.
9. Brundish, D. E., and J. Baddiley. 1968. Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate. Biochem. J. 110:573-582.
10. Carlson, C. S., S. F. Aldred, P. K. Lee, R. P. Tracy, S. M. Schwartz, M. Rieder, K. Liu, O. D. Williams, C. Iribarren, E. C. Lewis, M. Fornage, E. Boerwinkle, M. Gross, C. Jaquish, D. A. Nickerson, R. M. Myers, D. S. Siscovick, and A. P. Reiner. 2005. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am. J. Hum. Genet. 77:64-77.
11. Christodoulides, M., J. S. Everson, B. L. Liu, P. R. Lambden, P. J. Watt, E. J. Thomas, and J. E. Heckels. 2000. Interaction of primary human endometrial cells with Neisseria gonorrhoeae expressing green fluorescent protein. Mol. Microbiol. 35:32-43.
12. Culley, F. J., K. B. Bodman-Smith, M. A. Ferguson, A. V. Nikolaev, N. Shantilal, and J. G. Raynes. 2000. C-reactive protein binds to phosphorylated carbohydrates. Glycobiology 10:59-65.
13. Culley, F. J., R. A. Harris, P. M. Kaye, K. P. McAdam, and J. G. Raynes. 1996. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J. Immunol. 156:4691-4696.
14. Eklund, C., R. Huttunen, J. Syrjanen, J. Laine, R. Vuento, and M. Hurme. 2006. Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia. Scand. J. Infect. Dis. 38:1069-1073.
15. Emonts, M., J. A. Hazelzet, R. de Groot, and P. W. Hermans. 2003. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3:565-577.
16. Gill, C. W., W. S. Bush, W. M. Burleigh, and C. L. Fischer. 1981. An evaluation of a C-reactive protein assay using a rate immunonephelometric procedure. Am. J. Clin. Pathol. 75:50-55.
17. Gillespie, S. H., S. Ainscough, A. Dickens, and J. Lewin. 1996. Phosphorylcholine-containing antigens in bacteria from the mouth and respiratory tract. J. Med. Microbiol. 44:35-40.
18. Gould, J. M., and J. N. Weiser. 2002. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J. Infect. Dis. 186:361-371.
19. Gould, J. M., and J. N. Weiser. 2001. Expression of C-reactive protein in the human respiratory tract. Infect. Immun. 69:1747-1754.
20. Heegaard, N. H., and F. A. Robey. 1993. A capillary electrophoresis-based assay for the binding of Ca2+ and phosphorylcholine to human C-reactive protein. J. Immunol. Methods. 166:103-110.
21. Jarvis, G. A., and N. A. Vedros. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55:174-180.
22. Jensen, T. D., H. Schonheyder, P. Andersen, and A. Stenderup. 1986. Binding of C-reactive protein to Aspergillus fumigatus fractions. J. Med. Microbiol. 21:173-177.
23. Kallstrom, H., M. K. Liszewski, J. P. Atkinson, and A. B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639-647.
24. McCabe, R. E., and J. S. Remington. 1984. C-reactive protein in patients with bacteremia. J. Clin. Microbiol. 20:317-319.
25. Mold, C., S. Nakayama, T. J. Holzer, H. Gewurz, and T. W. Du Clos. 1981. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J. Exp. Med. 154:1703-1708.
26. Morgan, B. P., and M. J. Walport. 1991. Complement deficiency and disease. Immunol. Today. 12:301-306.
27. Noursadeghi, M., M. C. Bickerstaff, J. R. Gallimore, J. Herbert, J. Cohen, and M. B. Pepys. 2000. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc. Natl. Acad. Sci. USA 97:14584-14589.
28. Schneider, M. C., R. M. Exley, H. Chan, I. Feavers, Y. H. Kang, R. B. Sim, and C. M. Tang. 2006. Functional significance of factor H binding to Neisseria meningitidis. J. Immunol. 176:7566-7575.
29. Serino, L., and M. Virji. 2000. Phosphorylcholine decoration of lipopolysaccharide differentiates commensal neisseriae from pathogenic strains: identification of licA-type genes in commensal neisseriae. Mol. Microbiol. 35:1550-1559.
30. Sharif, O., V. N. Bolshakov, S. Raines, P. Newham, and N. D. Perkins. 2007. Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunol. 8:1.
31. Shrive, A. K., G. M. T. Cheetham, D. Holden, D. A. A. Myles, W. G. Turnell, J. E. Volanakis, M. B. Pepys, A. C. Bloomer, and T. L. Greenhough. 1996. Three dimensional structure of human C-reactive protein. Nat. Struct. Biol. 3:346-354.
32. Stephens, D. S., L. H. Hoffman, and Z. A. McGee. 1983. Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells. J. Infect. Dis. 148:369-376.
33. Szalai, A. J., J. L. VanCott, J. R. McGhee, J. E. Volanakis, and W. H. Benjamin, Jr. 2000. Human C-reactive protein is protective against fatal Salmonella enterica serovar Typhimurium infection in transgenic mice. Infect. Immun. 68:5652-5656.
34. Tillet, W. S. F. T., Jr. 1930. Serological reactions in pneumonia with a non-protein fraction of pneumococcus. J. Exp. Med. 52:561-571.
35. Toropainen, M., L. Saarinen, E. Wedege, K. Bolstad, T. E. Michaelsen, A. Aase, and H. Kayhty. 2005. Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis. Infect. Immun. 73:4694-4703.
36. Tzeng, Y. L., and D. S. Stephens. 2000. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect. 2:687-700.
37. Volanakis, J. E., W. L. Clements, and R. E. Schrohenloher. 1978. C-reactive protein: purification by affinity chromatography and physiochemical characterisation. J. Immunol. Methods 23:285-295.
38. Weiser, J. N., J. B. Goldberg, N. Pan, L. Wilson, and M. Virji. 1998. The phosphorylcholine epitope undergoes phase variation on a 43-kilodalton protein in Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria gonorrhoeae. Infect. Immun. 66:4263-4267.
39. Weiser, J. N., N. Pan, K. L. McGowan, D. Musher, A. Martin, and J. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:631-640.
40. Woo, P., J. R. Korenberg, and A. S. Whitehead. 1985. Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J. Biol. Chem. 260:13384-13388.
41. Zhang, R., L. Becnel, M. Li, C. Chen, and Q. Yao. 2006. C-reactive protein impairs human CD14+ monocyte-derived dendritic cell differentiation, maturation and function. Eur. J. Immunol. 36:2993-3006.